Oregon Health & Science University

2019 Program schedule

Friday, September 6

7:30 a.m.
Registration check-in and breakfast

8:30 a.m.

8:45 a.m.
Is a Sea change Underway? Less Antiplatelets? More Antithrombotics?
Joaquin Cigarroa, M.D.

9:15 a.m.
Can we Ablate VF?
Samuel Asirvantham

9:45 a.m.
Panel Q & A

10 a.m.

10:30 a.m.
With the Low Risk TAVR Trial Outcomes, Who Should Still be Treated with Surgery?
Michael Mack, M.D., F.A.C.C.

11 a.m.
How to make the best of what you have, lessons learned from Transcatheter valve therapies
Firas Zahr, M.D.

11:30 a.m.
Panel Q & A

11:45 a.m.

1 p.m.
The Future of Hypertrophic Cardiomyopathy
Stephen Heitner, M.D.

1:30 p.m.
Cardio-Oncology: Understanding Interplay Between Cancer and Heart Disease for Improved Outcomes
Maros Ferencik, M.D., Ph.D.

2 p.m.
Panel Q & A

2:15 p.m.

2:45 p.m.
Update on Devices for Peripheral Interventions
Ehrin Armstrong, M.D.

3:15 p.m.
Learning from Failure: Novel Approaches to Exercise Training in Heart Failure with Preserved Ejection Fraction
Satyam (Tom) Sarma

3:45 p.m.
Panel Q & A

4 p.m.

4:15 p.m.
Treatment of Cardiac Arrhythmias Past and Present and a Glimpse into the Future
Melvin Scheinman, M.D.

5 p.m.

Saturday, September 7

7:30 a.m.

8:15 a.m.

8:30 a.m.
The Heart of the Matter: A Preventative Cardiologist's Perspective on Managing Type 2 Diabetes
Mikhail Kosiborod, M.D.

9:00 a.m.
New Treatments for Hypertriglyceridemia
Deepak Bhatt, M.D., M.P.H.

9:30 a.m.
Panel Q & A

9:45 a.m.

10:15 a.m.
The Role of Revascularization in Stable Ischemic Heart Disease
Judith Hochman, M.D., M.A.

10:45 a.m.
Obesity, Inflammation, and Atherosclerosis
Alan Chait, M.D.

11:15 a.m.
Panel Q & A

11:30 a.m.